Holowesko Partners Ltd. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 791 filers reported holding GLAXOSMITHKLINE PLC in Q2 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.

Quarter-by-quarter ownership
Holowesko Partners Ltd. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$2,829,000
-0.1%
65,0000.0%1.48%
+9.0%
Q1 2022$2,831,000
-1.3%
65,0000.0%1.36%
+16.2%
Q4 2021$2,867,000
+15.4%
65,0000.0%1.17%
+26.6%
Q3 2021$2,484,000
-4.0%
65,0000.0%0.92%
+40.9%
Q2 2021$2,588,000
+20.9%
65,000
+8.3%
0.66%
+14.3%
Q1 2021$2,141,000
-3.0%
60,0000.0%0.57%
-3.5%
Q4 2020$2,208,000
-82.1%
60,000
-81.7%
0.60%
-71.3%
Q3 2020$12,308,000
-7.7%
327,0000.0%2.07%
+29.7%
Q2 2020$13,338,000
-2.2%
327,000
-9.2%
1.60%
+6.9%
Q1 2020$13,640,000
+2802.1%
360,000
+3500.0%
1.49%
+5048.3%
Q4 2019$470,000
+10.1%
10,0000.0%0.03%
-14.7%
Q3 2019$427,000
+6.8%
10,0000.0%0.03%
+3.0%
Q2 2019$400,000
-4.3%
10,0000.0%0.03%
+3.1%
Q1 2019$418,000
+9.4%
10,0000.0%0.03%0.0%
Q4 2018$382,000
-5.0%
10,0000.0%0.03%
+6.7%
Q3 2018$402,000
-0.2%
10,0000.0%0.03%
+11.1%
Q2 2018$403,000
+3.1%
10,0000.0%0.03%0.0%
Q1 2018$391,000
+10.1%
10,0000.0%0.03%
+22.7%
Q4 2017$355,000
-12.6%
10,0000.0%0.02%
-31.2%
Q3 2017$406,000
-5.8%
10,0000.0%0.03%
+10.3%
Q2 2017$431,000
+2.1%
10,0000.0%0.03%
+16.0%
Q1 2017$422,00010,0000.02%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q2 2021
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 100,000$3,680,00012.40%
Black Creek Investment Management Inc. 7,443,061$273,905,0008.54%
KAHN BROTHERS GROUP INC 1,281,924$47,174,803,0008.23%
Camber Capital Management LP 3,500,000$128,800,0004.52%
Eversept Partners, LP 946,581$35,196,5224.13%
EQUITY INVESTMENT CORP 2,321,164$85,419,0003.98%
Galibier Capital Management Ltd. 575,741$21,187,0003.66%
Keystone Financial Planning, Inc. 217,399$8,000,0003.32%
CLIFFORD CAPITAL PARTNERS LLC 217,817$8,016,0003.14%
CLARK ESTATES INC/NY 485,000$17,848,0002.52%
View complete list of GLAXOSMITHKLINE PLC shareholders